Success Metrics

Clinical Success Rate
100.0%

Based on 10 completed trials

Completion Rate
100%(10/10)
Active Trials
0(0%)
Results Posted
20%(2 trials)

Phase Distribution

Ph phase_1
2
15%
Ph phase_3
10
77%

Phase Distribution

2

Early Stage

0

Mid Stage

10

Late Stage

Phase Distribution12 total trials
Phase 1Safety & dosage
2(16.7%)
Phase 3Large-scale testing
10(83.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

10 of 10 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

13

all time

Status Distribution
Completed(10)
Other(3)

Detailed Status

Completed10
unknown3

Development Timeline

Analytics

Development Status

Total Trials
13
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 12 (16.7%)
Phase 310 (83.3%)

Trials by Status

completed1077%
unknown323%

Recent Activity

0 active trials
Showing 5 of 13
completedphase_3

The Asia-Pacific Flexible Dose Study of Dapoxetine and Patient Satisfaction in Premature Ejaculation Therapy

NCT01063881
unknownphase_3

Observational Study of Pharmacological Treatment for Premature Ejaculation Concurrent With Erectile Dysfunction

NCT04361305
completedphase_3

Evaluation of the Clinical Efficacy and Safety of Dapoxetine, Combined Dapoxetine With Folic Acid and Combined Dapoxetine With Vitamin B12 in Treatment of Patients With Premature Ejaculation

NCT04085354
unknown

Discontinuation of Dapoxetine Treatment in Patients With Premature Ejaculation

NCT03018743
unknownphase_1

Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Udenafil and Dapoxetine

NCT01928563
View all 13 trials

Clinical Trials (13)

Showing 13 of 13 trials
NCT01063881Phase 3

The Asia-Pacific Flexible Dose Study of Dapoxetine and Patient Satisfaction in Premature Ejaculation Therapy

Completed
NCT04361305Phase 3

Observational Study of Pharmacological Treatment for Premature Ejaculation Concurrent With Erectile Dysfunction

Unknown
NCT04085354Phase 3

Evaluation of the Clinical Efficacy and Safety of Dapoxetine, Combined Dapoxetine With Folic Acid and Combined Dapoxetine With Vitamin B12 in Treatment of Patients With Premature Ejaculation

Completed
NCT03018743

Discontinuation of Dapoxetine Treatment in Patients With Premature Ejaculation

Unknown
NCT01928563Phase 1

Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Udenafil and Dapoxetine

Unknown
NCT01063855Phase 3

Concomitant Use of PriLigy in Men Treated for Erectile Dysfunction

Completed
NCT01419470Phase 1

Safety, Tolerability, Pharmacokinetics and Efficacy of YHD1044

Completed
NCT00210613Phase 3

A Study of Withdrawal Effects With Dapoxetine in the Treatment of Premature Ejaculation

Completed
NCT00210704Phase 3

A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation

Completed
NCT00229073Phase 3

A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation

Completed
NCT01230762Phase 3

An Open-Label Study of the Long-Term Safety of Dapoxetine HCl in the Treatment of Rapid Ejaculation

Completed
NCT00211107Phase 3

A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation.

Completed
NCT00211094Phase 3

A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation

Completed

All 13 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
13